Cargando…
Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy
Autores principales: | Cardillo, Giuseppe, Mokhles, Sahar, Williams, Norman, Macbeth, Fergus, Russell, Christopher, Treasure, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705879/ https://www.ncbi.nlm.nih.gov/pubmed/26372699 http://dx.doi.org/10.1038/bjc.2015.331 |
Ejemplares similares
-
Pulmonary metastasectomy: limits to credibility
por: Treasure, Tom, et al.
Publicado: (2021) -
Reply to ‘Comment on “The myth of pulmonary metastasectomy’”
por: Macbeth, Fergus, et al.
Publicado: (2020) -
Pulmonary metastasectomy: what is the practice and where is the evidence for effectiveness?
por: Treasure, Tom, et al.
Publicado: (2014) -
KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer
por: Renaud, S, et al.
Publicado: (2015) -
Reply: Comment on ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colo-rectal cancer'
por: Renaud, Stéphane, et al.
Publicado: (2015)